Clinical, virologic and phylogenetic features of hepatitis B infection in Iranian patients

Table 1 Clinical, serological, virological and biochemical features of patients infected with HBV (mean ± SD)

Clinica-status	Number (%)	Sex		Age (yr)	HBs Ag+	Anti HBs+	Anti HBc+	Hbe Ag+	Anti HBe+	ALT (IU/L)	AST (IU/L)	Alk (U/L)	T-Bil (mg/dL)	Albumin (g/dL)	HBV DNA (log copies/mL)
		M	F
Inactive HBsAg carriers	12 (19.4)	9	3	30.6 ±	12	0	12	3	9	38.3 ±	31.4 ±	282.2 ±	0.7 ±	4.77 ±	4.3 ±
				9.5						25.8	12.	199.9	0.241	1.25	1.57
Chronic hepatitis	30 (48.4)	25	5	34.5 ±	30	0	30	81	221	250.9 ±	104.4 ±	243.6 ±	1.17 ±	4.2 ±	5.31 ±
				11.6						120.7	74.7	125.4	0.49	0.7	1.48
Liver cirrhosis	13 (21.0)	9	4	44.5 ±	13	0	13	5	8	50.3 ±	64.6 ±	274.2 ±	1.41 ±	3.6 ±	5.8 ±
				9.4						18.8	32.2	229.3	0.63	0.67	2.03
HCC	7 (11.3)	6	1	47.7 ±	7	0	7	0	7	123.5 ±	285.1 ±	402 ±	2.92 ±	3.1 ±	7.22 ±
				13.7						64.1	196.8	114.3	1.5	0.48	2.01
Total	62 (100)	49	13	37.3 ±	62	0	62	16	46	178.7 ±	120.6 ±	274.2 ±	1.36 ±	3.83 ±	5.2 ±
		(79.00%)	(21.00%)	12.3						93.7	91.1	165.6	0.89	0.91	1.57

¹One patient had both positive HBeAg and anti-HBe status.